Breadcrumb Who we work with | Partners Partner testimonials Partner testimonials Find out more how UICC and its partners are working together and connecting for global impact. UICC believes that partnering with our members and the private sector can deliver high-impact results. Read on to find out how UICC and its partners are working together and connecting for global impact. UICC is proud to partner with some of the largest cancer organisations in the world, including the National Cancer Institute, the Centre for Disease Control, the World Cancer Research Fund International, the American Cancer Society, the Swiss Cancer League - to name a few. Their continued support and engagement have been fundamental to help us achieve tremendous results at the global and political levels - for the benefit of the global cancer community. We are excited to continue to partner with these strong and influential cancer societies over the coming years and to welcome new partners from around the world. Working hand in hand with our partners “The Swiss Cancer League has been committed for many years to supporting cancer organisations in low- and middle-income settings, by providing them access to the UICC community and its advocacy, global resources, training and collaboration opportunities. Today, they require this support more than ever, and our organisation will continue helping those most in need.” Daniela de la Cruz, CEO Swiss Cancer League “At Icon Group we are particularly proud to be working closely with UICC through our Vanguard partnership as it provides us with the unique opportunity to engage with key decision makers in cancer control, share our expertise and knowledge with 1,000+ UICC members globally, and advocate to integrate cancer control into the world health and development agenda.” Mark Middleton, CEO ICON Group “We are proud that our partnership with UICC on the SPARC mBC Challenge continues to make a positive impact on the lives of women with metastatic breast cancer around the world. We are committed to working with the global breast cancer community to help deliver high-quality and far-reaching care to patients in need.” Andy Schmeltz, President and General Manager Pfizer “World Cancer Day is a special day because people striving to end cancer unite and they recommit to this extremely important cause. By working together, we can all make a difference. We are proud to support World Cancer Day and help people with cancer to live better, longer lives.” Severin Schwan, CEO Roche Group “Fondation Philanthropia is delighted to work with our UICC partners to address cancer globally. Investing in the organisation’s capacity building plans means that we are impacting more cancer organisations around the world and helping them improve their skills and competencies. We represent a range of philanthropists committed to tackling the staggering burden of cancer and are convinced that new approaches should be championed, and consider capacity to be a critical component.” Luc Giraud-Guigues, Head of Philanthropy Fondation Philanthropia “We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications MSD “As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
“At Icon Group we are particularly proud to be working closely with UICC through our Vanguard partnership as it provides us with the unique opportunity to engage with key decision makers in cancer control, share our expertise and knowledge with 1,000+ UICC members globally, and advocate to integrate cancer control into the world health and development agenda.” Mark Middleton, CEO ICON Group “We are proud that our partnership with UICC on the SPARC mBC Challenge continues to make a positive impact on the lives of women with metastatic breast cancer around the world. We are committed to working with the global breast cancer community to help deliver high-quality and far-reaching care to patients in need.” Andy Schmeltz, President and General Manager Pfizer “World Cancer Day is a special day because people striving to end cancer unite and they recommit to this extremely important cause. By working together, we can all make a difference. We are proud to support World Cancer Day and help people with cancer to live better, longer lives.” Severin Schwan, CEO Roche Group “Fondation Philanthropia is delighted to work with our UICC partners to address cancer globally. Investing in the organisation’s capacity building plans means that we are impacting more cancer organisations around the world and helping them improve their skills and competencies. We represent a range of philanthropists committed to tackling the staggering burden of cancer and are convinced that new approaches should be championed, and consider capacity to be a critical component.” Luc Giraud-Guigues, Head of Philanthropy Fondation Philanthropia “We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications MSD “As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
“We are proud that our partnership with UICC on the SPARC mBC Challenge continues to make a positive impact on the lives of women with metastatic breast cancer around the world. We are committed to working with the global breast cancer community to help deliver high-quality and far-reaching care to patients in need.” Andy Schmeltz, President and General Manager Pfizer “World Cancer Day is a special day because people striving to end cancer unite and they recommit to this extremely important cause. By working together, we can all make a difference. We are proud to support World Cancer Day and help people with cancer to live better, longer lives.” Severin Schwan, CEO Roche Group “Fondation Philanthropia is delighted to work with our UICC partners to address cancer globally. Investing in the organisation’s capacity building plans means that we are impacting more cancer organisations around the world and helping them improve their skills and competencies. We represent a range of philanthropists committed to tackling the staggering burden of cancer and are convinced that new approaches should be championed, and consider capacity to be a critical component.” Luc Giraud-Guigues, Head of Philanthropy Fondation Philanthropia “We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications MSD “As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
“World Cancer Day is a special day because people striving to end cancer unite and they recommit to this extremely important cause. By working together, we can all make a difference. We are proud to support World Cancer Day and help people with cancer to live better, longer lives.” Severin Schwan, CEO Roche Group “Fondation Philanthropia is delighted to work with our UICC partners to address cancer globally. Investing in the organisation’s capacity building plans means that we are impacting more cancer organisations around the world and helping them improve their skills and competencies. We represent a range of philanthropists committed to tackling the staggering burden of cancer and are convinced that new approaches should be championed, and consider capacity to be a critical component.” Luc Giraud-Guigues, Head of Philanthropy Fondation Philanthropia “We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications MSD “As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
“Fondation Philanthropia is delighted to work with our UICC partners to address cancer globally. Investing in the organisation’s capacity building plans means that we are impacting more cancer organisations around the world and helping them improve their skills and competencies. We represent a range of philanthropists committed to tackling the staggering burden of cancer and are convinced that new approaches should be championed, and consider capacity to be a critical component.” Luc Giraud-Guigues, Head of Philanthropy Fondation Philanthropia “We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications MSD “As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
“We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications MSD “As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
“As a Vanguard partner, BD (Becton, Dickinson and Company) engages with UICC around the areas of antimicrobial resistance (AMR), cervical cancer and delivery (preparation, transportation, infusion) of oncology medicines. Our partnership helps shape global initiatives based on our common goals and vision, and increase our visibility among the global health community.” BD (Becton, Dickinson and Company) “At BMS we put patients at the center of everything we do and we are very proud to work in partnership with UICC to further position the patient voice at the global stage. The Country to Country for Cancer Ride (C2C4C) represents an excellent example of shared value partnership where we work hand in hand crafting new ways to collaborate to ultimately make a difference and greater impact” Cathy Trzaskawka, Head, Global Advocacy Bristol-Myers Squibb Related pages Partnership is at the heart of our strategy, with our members, governments, companies and individuals. Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control. UICC continues to deliver impact for cancer care through strategic partnerships. Find out how in our Partner related news and blog articles below. Invest in our priority areas and help us drive change globally. We value our partnerships and strive to build mutually beneficial relationships. Last update Wednesday 17 May 2023 Share this page
